(40) showed serum levels of TNF-α were decreased in 6/9 malignant melanoma (MM) patients with complete remission (CR), partial remission (PR) or long-term stable disease (long SD), and elevated in six patients with progressive disease (PD) (P<0.05). The gene discussed is TNF; the disease is melanoma.